SUNY Upstate Medical Center

The trials here

What the 13 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease2 trials
• Multiple sclerosis2 trials
• Acute myeloid leukaemia1 trial
• Childhood cancers1 trial
• Chronic myeloid leukaemia1 trial
• Crohn's disease1 trial
• Cytomegalovirus infection1 trial
• Glioblastoma1 trial
• HIV1 trial
• Lupus (SLE)1 trial
• Meningioma1 trial
• Multiple myeloma1 trial
• and 2 more

Phase

• Phase 25 trials
• Phase 33 trials
• Phase 42 trials

Status

• Active, not recruiting4 trials
• Completed4 trials
• Recruiting2 trials
• Terminated2 trials
• Withdrawn1 trial

Lead sponsor

• Alector Inc.2 trials
• Novartis Pharmaceuticals2 trials
• Alliance Foundation Trials, LLC.1 trial
• Biogen1 trial
• Genentech, Inc.1 trial
• and 6 more

Running trials

• Recruiting

  Continuous Dual Aspiration Technique With Zoom System for Stroke

  NCT07491952· Imperative Care, Inc.· Source

  Contact: Saptarshi Prachi

• Active, not recruiting

  Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia

  NCT05384587· Phase 2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

  NCT05090371· Phase 4· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

  NCT04895241· Phase 3· Biogen· Source

• Active, not recruiting

  Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM

  NCT04009109· Phase 2· Alliance Foundation Trials, LLC.· Source

• Recruiting

  Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

  NCT04427384· GT Medical Technologies, Inc.· Source

  Contact: Harish Babu, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Glioblastoma1 recruiting
• Meningioma1 recruiting
• Stroke1 recruiting

Closed trials

• Terminated

  A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease

  NCT05744401· Phase 2· Alector Inc.· Source

• Completed

  A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

  NCT05388474· Theratechnologies· Source

• Recruiting

  A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

  NCT04779320· Phase 3· Takeda· Source

• Terminated

  A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

  NCT05085366· Phase 3· ModernaTX, Inc.· Source

• Completed

  CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old

  NCT04269213· Phase 2· Roswell Park Cancer Institute· Source

• Completed

  A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

  NCT04592874· Phase 2· Alector Inc.· Source

• Completed

  Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab

  NCT04377555· Phase 4· Genentech, Inc.· Source